Skip to main content
Top

Clinical & Experimental Metastasis

Issue 3/2000

Content (9 Articles)

Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-β-1-integrin complex formation

Yueqin Liu, Edward Kyle, Ronald Lieberman, James Crowell, Gary Kelloff, Raymond C. Bergan

Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models

Michael Bouvet, Meng Yang, Stephanie Nardin, Xiaoen Wang, Ping Jiang, Eugene Baranov, A.R. Moossa, Robert M. Hoffman

Persistence of human vascular endothelium in experimental human prostate cancer bone tumors

Jeffrey A. Nemeth, Jason W. Roberts, Chadwick M. Mullins, Michael L. Cher

In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2

Sajani S. Lakka, Santhi D. Konduri, Sanjeeva Mohanam, Garth L. Nicolson, Jasti S. Rao

Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades

Sajani S. Lakka, Sushma L. Jasti, Anthanassios P. Kyritsis, W.K. Alfred Yung, Francis Ali-Osman, Garth L. Nicolson, Jasti S. Rao

Expression of bone sialoprotein and osteopontin in breast cancer bone metastases

Tharwat Ibrahim, Iona Leong, Otto Sanchez-Sweatman, Rama Khokha, Jaro Sodek, Howard C. Tenenbaum, Bernard Ganss, Sela Cheifetz

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine